Syros Pharmaceuticals Inc SYRS Stock Price Today, News, Quotes, FAQs and Fundamentals
Contents: Recently Viewed Tickers Syros Pharmaceuticals, Inc. – common stock (SYRS): Price and Financial Metrics Price Target and Rating Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome Price and EPS Surprise Chart Financial Forecast Raised $60 million in an IPO on Thursday, June 30th 2016. The […]